Adamax (10 mg vial)

Protocol Overview

Concise summary of the regimen.

Dosing & Reconstitution

Frequency is once daily by subcutaneous injection for the whole course. At 10 mg/mL every step in this protocol lands at or below 10 units, so a 30 unit or 50 unit insulin syringe reads far more cleanly than a 100 unit barrel, and the 750 mcg step at 7.5 units calls for a barrel with half unit gradations. Injections go into pinched subcutaneous tissue at 45 to 90 degrees, without aspirating, slowly and steadily, with the needle held 5 to 10 seconds before withdrawal. Sites are rotated systematically across abdomen, thighs, and upper arms to avoid lipohypertrophy. Cycle length is 8 to 12 weeks, extendable to 16, with an equal off-cycle break afterward to prevent tolerance.

Results Timeline

Sequence described in the research record. Individual response varies.

• Weeks 1 to 2: titration opens at 300 mcg daily, 3 units per injection, establishing tolerance and a consistent daily routine.
• Weeks 3 to 4: step up to 500 mcg daily, 5 units per injection.
• Weeks 5 to 6: step up to 750 mcg daily, 7.5 units per injection.
• Weeks 7 to 8: reach the 1,000 mcg daily maintenance dose, 10 units (0.10 mL) per injection. The standard 8 week course ends here.
• Weeks 9 to 16: optional extension holding 1,000 mcg daily at the same once daily cadence, followed by an off-cycle break of equal length.

Reconstitution Steps

1. Draw 1.0 mL bacteriostatic water with a sterile syringe.
2. Inject slowly down the vial wall; avoid foaming.
3. Gently swirl or roll the vial until the powder fully dissolves (do not shake).
4. Label with date and concentration; refrigerate at 2 to 8 °C, protected from light, and use within 1 to 2 weeks. At 10 mg/mL, 1 unit = 0.01 mL » 100 mcg on a U-100 insulin syringe, so 300 mcg is 3 units, 500 mcg is 5 units, 750 mcg is 7.5 units, and 1,000 mcg is 10 units.

Storage Instructions

Proper storage preserves peptide quality.

• Lyophilized: store at minus 20 °C in dry, dark conditions and keep vials in the original packaging.
• Reconstituted: refrigerate at 2 to 8 °C and use within 1 to 2 weeks for optimal potency.

• Avoid freeze-thaw: reconstituted solution is not refrozen, since repeated cycles degrade the peptide.
• Allow lyophilized vials to reach room temperature before opening to limit condensation, and protect from light and heat throughout.

Supplies Needed

Planning math is based on the 8 to 16 week daily protocol with gradual titration, which consumes about 2.1 mg in each of the first two weeks and rises to 7.0 mg per week once the 1,000 mcg maintenance dose is reached.

Peptide Vials (Adamax, 10 mg vial):

• An 8 week course uses about 36 mg of Adamax, which the master sheet plans as about 4 vials of 10 mg. A 12 week course uses about 60 mg and about 7 vials, and a 16 week course uses about 88 mg and about 9 vials.

Insulin Syringes (U-100):

• Per week: 7 U-100 insulin syringes, one per day, with a 30 unit or 50 unit barrel preferred at these small volumes.
• Full cycle: 56 syringes at 8 weeks, 84 at 12 weeks, and 112 at 16 weeks.

Bacteriostatic Water (10 mL bottles):

• At 1.0 mL of bacteriostatic water per 10 mg vial, one 10 mL bottle covers 10 vials, so a single bottle covers the whole 16 week course.

Alcohol Swabs:

• Per injection: 2 alcohol swabs, one for the vial stopper and one for the skin, which is 14 per week.
• Full cycle: 112 swabs at 8 weeks, 168 at 12 weeks, and 224 at 16 weeks, which is three boxes of 100.

Important Notes

Practical considerations for consistency and safety.

• Use a new sterile insulin syringe for each injection and dispose of it in a sharps container.
• Rotate injection sites across abdomen, thighs, and upper arms daily to reduce local irritation.
• Document the daily dose, the injection site, and subjective effects such as cognition, mood, and sleep to track response across the cycle.
• Every dose in this protocol sits at or below 10 units at 10 mg/mL, so a 30 unit or 50 unit insulin syringe is the sensible barrel, and the 750 mcg step at 7.5 units needs half unit gradations to measure accurately.
• At 10 mg/mL one vial holds 100 units of solution, which is 10 days at the 1,000 mcg maintenance dose and sits comfortably inside the 1 to 2 week window for reconstituted material. At the 300 mcg starting dose the same vial would outlast that window, so part of the first vial is discarded rather than carried on, and the vial counts above already allow for that.
• Regulatory Note: Adamax is not an approved drug for human therapeutic use and is supplied for research purposes only, not for human consumption. Long-term human data on Adamax specifically is limited, and the master sheet does not record a WADA classification for this compound.

How This Works

Adamax is structurally derived from Semax, a well studied ACTH(4-10) analog with nootropic properties. Semax increases brain-derived neurotrophic factor (BDNF) expression and enhances TrkB receptor sensitivity in the hippocampus, promoting neuroplasticity, synaptic formation, and neuronal survival. The peptide modulates neurotransmitter systems including dopamine and serotonin and activates intracellular signaling cascades such as the cAMP/CREB pathway, leading to improved memory, learning, and stress resilience. The adamantane moiety on Adamax confers greater lipophilicity and enzymatic stability than Semax, enabling more efficient blood-brain barrier crossing and a prolonged in vivo half-life. Preclinical data suggest 2 to 3 times greater efficacy in cognitive and endurance outcomes compared with standard Semax.

Benefits & Side Effects

Observations from the published record.

• Enhanced cognitive function: improved learning, memory consolidation, and mental clarity.
• Neuroprotection: supports neuronal survival and recovery in ischemic and oxidative stress models.
• Mood support: modulates dopamine and serotonin systems, potentially improving stress resilience and reducing anxiety.
• Neuroplasticity: increases BDNF levels, promoting synaptic growth and neural connectivity.
• Generally well tolerated in Semax studies, with no major adverse effects reported in short term human trials.
• Mild injection-site reactions such as redness, itching, and minor discomfort may occur with subcutaneous administration, and long-term human data on Adamax specifically is limited, with safety extrapolated from Semax clinical use.

Lifestyle Factors

Complementary strategies for best outcomes.

• A nutrient-dense diet rich in omega-3 fatty acids, antioxidants, and B vitamins pairs well with the protocol.
• Regular aerobic exercise and resistance training enhance BDNF expression synergistically.
• Consistent sleep of 7 to 9 hours nightly supports memory consolidation and neural recovery.
• Stress management such as meditation and breathwork, along with limiting alcohol and processed foods, helps protect the neuroplasticity pathways this protocol targets.

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

1. Clean the vial stopper and skin with alcohol; allow to dry.
2. Pinch a skinfold; insert the needle at 45 to 90 degrees into subcutaneous tissue.
3. Do not aspirate for subcutaneous injections; inject slowly and steadily.
4. Wait 5 to 10 seconds before withdrawing; dispose of syringe in sharps container.
5. Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.

References

Source citations for further reading.

1. Semax binds specific brain sites and increases BDNF protein in rat basal forebrain (Journal of Neurochemistry, 2006).
2. Adamantane modifications enhance peptide stability and CNS penetration (Medicinal Chemistry Letters).